Anubroto Pal - Publications

Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer.

Journal: Colloids and surfaces. B, Biointerfaces

Published: May 20, 2026

Supersaturated SNEDDS for enhancing the bioavailability of lapatinib ditosylate: A mechanistic approach to bridge the solubilization-absorption gap.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: December 20, 2025

Parthenolide attenuates neuroinflammation by targeting NLRP3 inflammasome & mitochondrial dysfunction in experimental diabetic neuropathy.

Journal: Neuropharmacology

Published: June 26, 2025

Vitexin mitigates AIM2 inflammasome-mediated mitochondrial dysfunction and neuroinflammation in chronic constriction injury induced neuropathy model.

Journal: International immunopharmacology

Published: February 25, 2025

Design and synthesis of novel 3,7-dihydro-1H-purine-2,6-diones as DPP-4 inhibitors: An in silico, in vitro and in vivo approach.

Journal: European journal of medicinal chemistry

Published: September 29, 2024

Bay 11-7082 mitigates oxidative stress and mitochondrial dysfunction via NLRP3 inhibition in experimental diabetic neuropathy.

Journal: Life sciences

Published: September 02, 2024

Vitamin K2 Ameliorates Diabetes-Associated Cognitive Decline by Reducing Oxidative Stress and Neuroinflammation.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: August 02, 2024

Spatiotemporally Controlled Release of Etamsylate from Bioinspired Peptide-Functionalized Nanoparticles Arrests Bleeding Rapidly and Improves Clot Stability in a Rabbit Internal Hemorrhage Model.

Journal: ACS biomaterials science & engineering

Published: July 10, 2024